Cheah: The long-term aim is to drive breakthroughs in areas like vaccine development, advanced cell culture systems and translational research for regenerative medicine.
SINCE his school days, Evan Cheah has been passionate about science. It is no surprise, then, that after earning two master’s degrees and a PhD in Health Science, he established his own startup, Inno Therapeutics, in 2018.
Inno Therapeutics specialises in drug development, vaccine innovation, and cellular therapeutic research, development, and manufacturing.
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
